We are live on ! Find out more
VIVS

VivoSim Labs
VIVS

117 hedge funds and large institutions have $67M invested in VivoSim Labs in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 28 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 28

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

2% more funds holding

Funds holding: 115 → 117 (+2)

0.01% more ownership

Funds ownership: 0.1% → 0.1% (+0.01%)

13% less capital invested

Capital invested by funds: $76.7M → $67M (-$9.66M)

65% less call options, than puts

Call options by funds: $343K | Put options by funds: $989K

Holders
117
Holders Change
+2
Holders Change %
+1.74%
% of All Funds
2.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
36
Reduced
28
Closed
9
Calls
$343K
Puts
$989K
Net Calls
-$646K
Net Calls Change
+$338K

Top Buyers

1
AIM
ARK Investment Management
Florida
+$2.32M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$617K
3
Citadel Advisors
Citadel Advisors
Florida
+$576K
4
State Street
State Street
Massachusetts
+$423K
5
BlackRock
BlackRock
New York
+$297K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$465K
2
QIM
Quantitative Investment Management
Virginia
-$396K
3
VKH
Virtu KCG Holdings
New York
-$326K
4
QI
Quotient Investors
New York
-$285K
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$238K
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$283K +$98.2K +146 +48%
SPC
27
Sigma Planning Corp
Michigan
$253K +$32.3K +48 +14%
AllianceBernstein
28
AllianceBernstein
Tennessee
$245K +$56.5K +84 +28%
Cambridge Investment Research Advisors
29
Cambridge Investment Research Advisors
Iowa
$240K +$2.69K +4 +1%
LPL Financial
30
LPL Financial
California
$226K -$57.8K -86 -19%
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$226K – – –
TCM
32
Trent Capital Management
North Carolina
$222K +$237K +352 New
Manulife (Manufacturers Life Insurance)
33
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$217K +$19.5K +29 +9%
CS
34
Credit Suisse
Switzerland
$211K -$28.9K -43 -11%
AFG
35
Albion Financial Group
Utah
$201K – – –
Goldman Sachs
36
Goldman Sachs
New York
$197K -$55.8K -83 -21%
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$196K +$210K +313 New
MLICM
38
Metropolitan Life Insurance Company (MetLife)
New York
$180K – – –
QI
39
Quotient Investors
New York
$174K -$285K -424 -61%
ProShare Advisors
40
ProShare Advisors
Maryland
$164K -$12.8K -19 -7%
AIG
41
American International Group
New York
$161K +$21.5K +32 +14%
NFA
42
Nationwide Fund Advisors
Ohio
$147K -$12.8K -19 -8%
VOYA Investment Management
43
VOYA Investment Management
Georgia
$137K +$22.9K +34 +19%
LTFS
44
Ladenburg Thalmann Financial Services
Florida
$116K -$9.41K -14 -7%
PPA
45
Parametric Portfolio Associates
Washington
$108K -$3.36K -5 -3%
CAS
46
Cue Advisory Services
Arizona
$105K -$6.72K -10 -6%
UBS AM
47
UBS AM
Illinois
$104K – – –
PCM
48
Prelude Capital Management
New York
$102K – – –
AQR Capital Management
49
AQR Capital Management
Connecticut
$99K – – –
AG
50
Advisor Group
Arizona
$93K – – –
1
2
3 4 5

VIVS Hedge Fund Activity: Q2 2017 in Review

117 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q2 2017, worth a combined $67M — down 13% from $76.7M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new VIVS positions and 9 closed out — a net gain of 2 holders — while 36 added to existing stakes and 28 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $2.32M. The largest seller was Morgan Stanley, cutting an estimated $465K.

  • 117 institutional investors held VivoSim Labs (VIVS) as of Q2 2017, up from 115 in Q1 2017.
  • Funds reported $67M of VivoSim Labs stock for Q2 2017, down 13% quarter-over-quarter.
  • 11 funds opened new VivoSim Labs positions in Q2 2017 and 9 closed out, a net change of +2 holders.
  • The largest VivoSim Labs buyer in Q2 2017 was ARK Investment Management, an estimated $2.32M added.
  • The largest VivoSim Labs seller in Q2 2017 was Morgan Stanley, an estimated $465K sold.

Based on aggregated 13F filings for Q2 2017.